The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine Excipients Market Research Report 2024
Synopsis
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
Global Vaccine Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaccine Excipients market research.
Key manufacturers engaged in the Vaccine Excipients industry include Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax and Dynavax Technologies, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Vaccine Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Vaccine Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Vaccine Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Segment by Application
Research Applications
Commercial Applications
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vaccine Excipients report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
Global Vaccine Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaccine Excipients market research.
Key manufacturers engaged in the Vaccine Excipients industry include Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax and Dynavax Technologies, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Vaccine Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Vaccine Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Vaccine Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Segment by Application
Research Applications
Commercial Applications
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vaccine Excipients report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Vaccine Excipients Market Overview
1.1 Product Overview and Scope of Vaccine Excipients
1.2 Vaccine Excipients Segment by Type
1.2.1 Global Vaccine Excipients Market Value Comparison by Type (2023-2029)
1.2.2 Vaccine Stabilizers
1.2.3 Vaccine Emulsifiers
1.2.4 Vaccine Adjuvants
1.2.5 Preservatives
1.3 Vaccine Excipients Segment by Application
1.3.1 Global Vaccine Excipients Market Value by Application: (2023-2029)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Vaccine Excipients Market Size Estimates and Forecasts
1.4.1 Global Vaccine Excipients Revenue 2018-2029
1.4.2 Global Vaccine Excipients Sales 2018-2029
1.4.3 Global Vaccine Excipients Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vaccine Excipients Market Competition by Manufacturers
2.1 Global Vaccine Excipients Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vaccine Excipients Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vaccine Excipients Average Price by Manufacturers (2018-2023)
2.4 Global Vaccine Excipients Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vaccine Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Excipients, Product Type & Application
2.7 Vaccine Excipients Market Competitive Situation and Trends
2.7.1 Vaccine Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine Excipients Players Market Share by Revenue
2.7.3 Global Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine Excipients Retrospective Market Scenario by Region
3.1 Global Vaccine Excipients Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vaccine Excipients Global Vaccine Excipients Sales by Region: 2018-2029
3.2.1 Global Vaccine Excipients Sales by Region: 2018-2023
3.2.2 Global Vaccine Excipients Sales by Region: 2024-2029
3.3 Global Vaccine Excipients Global Vaccine Excipients Revenue by Region: 2018-2029
3.3.1 Global Vaccine Excipients Revenue by Region: 2018-2023
3.3.2 Global Vaccine Excipients Revenue by Region: 2024-2029
3.4 North America Vaccine Excipients Market Facts & Figures by Country
3.4.1 North America Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vaccine Excipients Sales by Country (2018-2029)
3.4.3 North America Vaccine Excipients Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine Excipients Market Facts & Figures by Country
3.5.1 Europe Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vaccine Excipients Sales by Country (2018-2029)
3.5.3 Europe Vaccine Excipients Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vaccine Excipients Sales by Country (2018-2029)
3.6.3 Asia Pacific Vaccine Excipients Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine Excipients Market Facts & Figures by Country
3.7.1 Latin America Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vaccine Excipients Sales by Country (2018-2029)
3.7.3 Latin America Vaccine Excipients Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vaccine Excipients Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vaccine Excipients Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Excipients Sales by Type (2018-2029)
4.1.1 Global Vaccine Excipients Sales by Type (2018-2023)
4.1.2 Global Vaccine Excipients Sales by Type (2024-2029)
4.1.3 Global Vaccine Excipients Sales Market Share by Type (2018-2029)
4.2 Global Vaccine Excipients Revenue by Type (2018-2029)
4.2.1 Global Vaccine Excipients Revenue by Type (2018-2023)
4.2.2 Global Vaccine Excipients Revenue by Type (2024-2029)
4.2.3 Global Vaccine Excipients Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine Excipients Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vaccine Excipients Sales by Application (2018-2029)
5.1.1 Global Vaccine Excipients Sales by Application (2018-2023)
5.1.2 Global Vaccine Excipients Sales by Application (2024-2029)
5.1.3 Global Vaccine Excipients Sales Market Share by Application (2018-2029)
5.2 Global Vaccine Excipients Revenue by Application (2018-2029)
5.2.1 Global Vaccine Excipients Revenue by Application (2018-2023)
5.2.2 Global Vaccine Excipients Revenue by Application (2024-2029)
5.2.3 Global Vaccine Excipients Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine Excipients Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Curia
6.1.1 Curia Corporation Information
6.1.2 Curia Description and Business Overview
6.1.3 Curia Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Curia Vaccine Excipients Product Portfolio
6.1.5 Curia Recent Developments/Updates
6.2 Croda Pharma
6.2.1 Croda Pharma Corporation Information
6.2.2 Croda Pharma Description and Business Overview
6.2.3 Croda Pharma Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Croda Pharma Vaccine Excipients Product Portfolio
6.2.5 Croda Pharma Recent Developments/Updates
6.3 Alfa Chemistry
6.3.1 Alfa Chemistry Corporation Information
6.3.2 Alfa Chemistry Description and Business Overview
6.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Alfa Chemistry Vaccine Excipients Product Portfolio
6.3.5 Alfa Chemistry Recent Developments/Updates
6.4 A & C
6.4.1 A & C Corporation Information
6.4.2 A & C Description and Business Overview
6.4.3 A & C Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.4.4 A & C Vaccine Excipients Product Portfolio
6.4.5 A & C Recent Developments/Updates
6.5 Avantor
6.5.1 Avantor Corporation Information
6.5.2 Avantor Description and Business Overview
6.5.3 Avantor Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Avantor Vaccine Excipients Product Portfolio
6.5.5 Avantor Recent Developments/Updates
6.6 GS
6.6.1 GS Corporation Information
6.6.2 GS Description and Business Overview
6.6.3 GS Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GS Vaccine Excipients Product Portfolio
6.6.5 GS Recent Developments/Updates
6.7 SEPPIC
6.6.1 SEPPIC Corporation Information
6.6.2 SEPPIC Description and Business Overview
6.6.3 SEPPIC Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SEPPIC Vaccine Excipients Product Portfolio
6.7.5 SEPPIC Recent Developments/Updates
6.8 Novavax
6.8.1 Novavax Corporation Information
6.8.2 Novavax Description and Business Overview
6.8.3 Novavax Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novavax Vaccine Excipients Product Portfolio
6.8.5 Novavax Recent Developments/Updates
6.9 Dynavax Technologies
6.9.1 Dynavax Technologies Corporation Information
6.9.2 Dynavax Technologies Description and Business Overview
6.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Dynavax Technologies Vaccine Excipients Product Portfolio
6.9.5 Dynavax Technologies Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi Vaccine Excipients Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Zhifei Biological
6.11.1 Zhifei Biological Corporation Information
6.11.2 Zhifei Biological Vaccine Excipients Description and Business Overview
6.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhifei Biological Vaccine Excipients Product Portfolio
6.11.5 Zhifei Biological Recent Developments/Updates
6.12 Escon
6.12.1 Escon Corporation Information
6.12.2 Escon Vaccine Excipients Description and Business Overview
6.12.3 Escon Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Escon Vaccine Excipients Product Portfolio
6.12.5 Escon Recent Developments/Updates
6.13 Rico Bio
6.13.1 Rico Bio Corporation Information
6.13.2 Rico Bio Vaccine Excipients Description and Business Overview
6.13.3 Rico Bio Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Rico Bio Vaccine Excipients Product Portfolio
6.13.5 Rico Bio Recent Developments/Updates
6.14 CSL Limited
6.14.1 CSL Limited Corporation Information
6.14.2 CSL Limited Vaccine Excipients Description and Business Overview
6.14.3 CSL Limited Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CSL Limited Vaccine Excipients Product Portfolio
6.14.5 CSL Limited Recent Developments/Updates
6.15 Creative Biolabs
6.15.1 Creative Biolabs Corporation Information
6.15.2 Creative Biolabs Vaccine Excipients Description and Business Overview
6.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Creative Biolabs Vaccine Excipients Product Portfolio
6.15.5 Creative Biolabs Recent Developments/Updates
6.16 Central Drug House
6.16.1 Central Drug House Corporation Information
6.16.2 Central Drug House Vaccine Excipients Description and Business Overview
6.16.3 Central Drug House Vaccine Excipients Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Central Drug House Vaccine Excipients Product Portfolio
6.16.5 Central Drug House Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Excipients Industry Chain Analysis
7.2 Vaccine Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Excipients Production Mode & Process
7.4 Vaccine Excipients Sales and Marketing
7.4.1 Vaccine Excipients Sales Channels
7.4.2 Vaccine Excipients Distributors
7.5 Vaccine Excipients Customers
8 Vaccine Excipients Market Dynamics
8.1 Vaccine Excipients Industry Trends
8.2 Vaccine Excipients Market Drivers
8.3 Vaccine Excipients Market Challenges
8.4 Vaccine Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
